Skip to Main Content

Paper Details

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
Blood Cancer J
59
2019
AML, acute myeloid leukemia, epigenetic modifier, founder leukemic clone, leukemic, leukemic cells, leukemic clone, patients, primary, spliceosome genes, therapy-related leukemia, tumor
Author NameAffiliation
Curtis GumbsThe University of Texas MD Anderson Cancer Center
Xingzhi SongThe University of Texas MD Anderson Cancer Center
Xingzhi SongThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Gautam BorthakurThe University of Texas MD Anderson Cancer Center
Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center
Hagop KantarjianThe University of Texas MD Anderson Cancer Center
Phillip A FutrealThe University of Texas MD Anderson Cancer Center
Farhad RavandiThe University of Texas MD Anderson Cancer Center
  • 1 - 10

Datasets

Release 1.2